0001493152-20-001391.txt : 20200130
0001493152-20-001391.hdr.sgml : 20200130
20200130171629
ACCESSION NUMBER: 0001493152-20-001391
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200130
DATE AS OF CHANGE: 20200130
EFFECTIVENESS DATE: 20200130
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hoverink Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001586494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463590875
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-359414
FILM NUMBER: 20562315
BUSINESS ADDRESS:
STREET 1: 1801 CENTURY PARK EAST
STREET 2: 24TH FLOOR
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 424 772 2191
MAIL ADDRESS:
STREET 1: 1801 CENTURY PARK EAST
STREET 2: 24TH FLOOR
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: Hoverink International Holdings Inc.
DATE OF NAME CHANGE: 20140717
FORMER COMPANY:
FORMER CONFORMED NAME: Sky Run Acqusition Corp
DATE OF NAME CHANGE: 20130911
D
1
primary_doc.xml
X0708
D
LIVE
0001586494
Hoverink Biotechnologies, Inc.
1801 CENTURY PARK EAST
24TH FLOOR
LOS ANGELES
CA
CALIFORNIA
90067
866-443-4666
DELAWARE
Hoverink Int, Holdings Inc
Hoverink International Holdings Inc.
Sky Run Acqusition Corp
Corporation
true
Cyrus
Sajna
1801 PARK EAST
24 Floor
Los Angeles
CA
CALIFORNIA
90067
Executive Officer
Director
Davidra
Nicole
Sajna
1801 PARK EAST
24 Floor
Los Angeles
CA
CALIFORNIA
90067
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
true
true
true
true
Common Stock
false
0
None
None
None
None
NONE
NONE
XX
Unknown
XX
All States
false
8389900
0
8389900
true
0
0
0
0
0
We intend to use the proceeds from this offering to: Repay existing debt and R&D Expenses and for working capital.
false
Hoverink Biotechnologies, Inc.
/s/ Cyrus Sajna
Cyrus Sajna
CEO
2020-01-30